Recent News & Updates in Botox Training, Aesthetic Medicine & GLP-1 Medical Weight Management

The “Wolverine Stack” pairs BPC-157 and TB-500 on the promise of faster tissue repair, but the combination has never been tested in a human clinical trial. This review covers what the evidence and regulatory record actually show, so providers can answer patient questions with confidence.

The June 2026 FDA approval of SKINVIVE by JUVÉDERM for horizontal neck lines gives aesthetic providers a new on-label option for an area that has historically relied on off-label approaches. Understanding where it fits — and where it doesn’t — is what separates confident treatment planning from guesswork.

IAPAM is offering July 4th pricing on both Safe Start training paths through July 8, 2026 — plus a free Introduction to Stem Cells and Exosomes course ($250 value) with every enrollment.

Building a profitable aesthetic practice requires more than clinical skill — it requires understanding the unit economics, patient lifetime value, and retention strategies that separate high-performing practices from the rest. This article breaks down the financial architecture behind sustainable aesthetic medicine, from service mix margins to evidence-based retention data.

What Providers Need to Know Now: May 2025 GLP-1 Updates GLP-1 medications continue to make headlines—and for good reason. These powerful agents are proving useful